What About Insurance?

More and more genetic tests are being developed to determine people's risk for disease, but as NPR's Michelle Andrews reports at the Shots blog, don't expect insurance companies to pay for all of the tests. Insurers, she says, typically only cover a test if there is strong evidence that there's a health benefit.

"You don't test for testing's sake," Susan Pisano, a spokesperson for the trade group America's Health Insurance Plans, tells Andrews.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.